News
November 18th, 2025: Consortium meeting
The ESOHISTO consortium gathered in Munich on November 18-19, 2026, for its second Consortium meeting, bringing together all partners to review progress and plan the next steps of the project.
During the meeting, the Consortium presented updates on the development of ESOHISTO’s innovative optical imaging technologies aimed at enabling high-resolution, non-invasive visualization of tissue microstructure. The discussions highlighted important technical achievements over the past months and helped align ongoing work across the consortium.
The meeting also provided an opportunity for in-depth technical exchanges to strengthen collaboration between partners.
The consortium would like to thank our partners at Helmholtz Munich for hosting the meeting and for facilitating productive discussions.
Funded by the European Innovation Council under the Pathfinder programme, ESOHISTO aims to advance next-generation optical imaging technologies for biomedical applications.
A major research milestone related to the ESOHISTO Project has been published in the journal Nature Biomedical Engineering, demonstrating a powerful new approach for early detection of esophageal cancer.
The study, led by researchers from the ESOHISTO consortium, combines optical coherence tomography (OCT) with optoacoustic imaging in a capsule-based imaging technology – also an important technological basis for the ESOHISTO Project.
By integrating these complementary modalities into a single tethered capsule endoscope, the system can simultaneously visualize tissue microstructure and microvascular features in the esophagus, producing high-resolution 3D images across a full 360° scan. In pilot experiments involving animal models and human tissue samples from Barrett’s esophagus patients, the technique successfully distinguished between healthy tissue, precancerous changes, and malignant lesions.
The work builds on earlier developments from the ESOTRAC Project and provides an important scientific foundation for the ESOHISTO project. Within ESOHISTO, the consortium is advancing this technology toward in-vivo histology, including the integration of confocal endomicroscopy to enable cellular-level imaging during endoscopic examinations.
By combining structural, vascular, and potentially molecular imaging within a single capsule platform, ESOHISTO aims to create next-generation endoscopic tools for early detection of esophageal cancer, reducing the need for multiple biopsies and enabling earlier, more effective treatment.
August 26th, 2025: LISAvienna August Newsletter.
LISAvienna, a leading cluster platform for life sciences in Vienna established at the interface of Austria Wirtschaftsservice and the Vienna Business Agency, has released its August 2025 Newsletter. The newsletter provides regular updates on developments across Vienna’s life sciences sector.We are pleased to share that ESOHISTO was featured in this August edition, highlighting our contribution on new endoscopy technology enabling early detection of esophagal cancer. Link
February 17-18, Vienna: ESOHISTO kick-off meeting The ESOHISTO consortium gathered in the heart of central Europe – Vienna, for the kick-off meeting of the project. We used this opportunity to have a recap of the achievements and challenges we met in ESOTRAC, a successfully implemented European Union funded project that laid the foundation of ESOHISTO. With the ensuing passion from this previous project, the consortium was motivated and decided on the strategies to fulfill the visions we have for ESOHISTO.
